Anaptysbio (ANAB) Interest Coverage Ratio Growth (1y) (2017 - 2019)
Anaptysbio (ANAB) Interest Coverage Ratio Growth (1y) (2017 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Anaptysbio |
1.66 Bn |
1.38 Bn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2019 |
-106.59% |
| Sep 30, 2019 |
-233.05% |
| Jun 30, 2019 |
-186.93% |
| Mar 31, 2019 |
-121.57% |
| Dec 31, 2018 |
-243.52% |
| Sep 30, 2018 |
-110.00% |
| Jun 30, 2018 |
-468.07% |
| Mar 31, 2018 |
-49.71% |
| Dec 31, 2017 |
45.16% |
| Sep 30, 2017 |
-116.94% |
| Jun 30, 2017 |
-128.57% |
| Mar 31, 2017 |
-135.62% |
